Typhim Vi

Typhim Vi

vaccine, typhoid


sanofi pasteur


Zuellig Pharma
Concise Prescribing Info
Salmonella typhi polysaccharides (Ty 2 strain)
Prevention of typhoid fever in adults & childn >2 yr.
Dosage/Direction for Use
0.5 mL IM or SC inj as single dose. Revaccination every 2-3 yr if risk of exposure continues.
Hypersensitivity to vaccine or formaldehyde. Postpone vaccination in acute febrile disease.
Special Precautions
Anaphylactic reaction. Not to be inj intravascularly. Not for protection against Salmonella paratyphi A or B or non-typhoidal salmonella. Syncope; thrombocytopenia or bleeding disorders. Reduced immunogenicity by immunosuppressive treatment or immunodeficiency. Pregnancy. Not to be used in childn <2 yr.
Adverse Reactions
Myalgia; inj site pain, erythema, swelling, oedema & induration, malaise, fatigue/asthenia. Fever.
ATC Classification
J07AP03 - typhoid, purified polysaccharide antigen ; Belongs to the class of typhoid bacterial vaccines.
Typhim Vi vaccine (inj) (pre-filled syringe) 25 mcg/0.5 mL
0.5 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in